How accurately can MRI detect indolent disease?

Current Opinion in Urology

Volumn 24, Issue 3, 2014, Pages 264-269

  Ouzzane, Adil ^a,b   Puech, Philippe ^a,b   Villers, Arnauld ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

biopsy; diagnosis; magnetic resonance imaging; prostatic neoplasm; watchful waiting

Indexed keywords

CANCER DIAGNOSIS; CANCER SURGERY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SURVEILLANCE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TUMOR BIOPSY; BIOPSY; CANCER GRADING; EARLY DIAGNOSIS; MALE; PATHOLOGY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTOR; TIME; TUMOR VOLUME; WATCHFUL WAITING;

BIOPSY; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUMOR BURDEN; WATCHFUL WAITING;

EID: 84898543478     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0000000000000047     Document Type: Review

References (18)

1. Patel U, Dasgupta P, Amoroso P, et al. Infection after transrectal ultrasonography- guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 2012; 109:1781-1785.
2. Rider JR, Sandin F, Andren O, et al. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. Eur Urol 2013; 63:88-96.
3. Thompson J, Lawrentschuk N, Frydenberg M, et al. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer. BJU Int 2013; 112 (Suppl 2):6-20.
4. Wolters T, Roobol MJ, van Leeuwen PJ, et al. A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 2011; 185:121-125.
5. Rais-Bahrami S, Siddiqui MM, Turkbey B, et al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol 2013; 190:1721-1727.
6. Sonn GA, Chang E, Natarajan D, et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 2014; 65:809-815.
7. Numao N, Yoshida S, Komai Y, et al. Usefulness of prebiopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol 2013; 190:502-508.
8. Vargas HA, Akin O, Afaq A, et al. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol 2012; 188:1732-1738.
9. Yerram NK, Volkin D, Turkbey B, et al. Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int 2012; 110:783-788.
10. Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA, et al. Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Invest Radiol 2013; 48:152-157.
11. Kasivisvanathan V, Dufour R, Moore CM, et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 2013; 189:860-866.
12. Arumainayagam N, Ahmed HU, Moore CM, et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. Radiology 2013; 268:761-769.
13. Abd-Alazeez M, Ahmed HU, Arya M, et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level - can it rule out clinically significant prostate cancer? Urol Oncol 2014; 32:e17-e22.
14. Abd-Alazeez M, Kirkham A, Ahmed AU, et al. Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. Prostate Cancer Prostatic Dis 2014; 17:40-46.
15. Turkbey B, Mani H, Aras O, et al. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 2012; 188:1157-1163.
16. Borofsky MS, Rosenkrantz AB, Abraham N, et al. Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy? Urology 2013; 81:1279-1283.
17. Lee DH, Koo KC, Lee SH, et al. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis. J Urol 2013; 190:1213-1217.
18. Park BH, Jeon HG, Choo SH, et al. Role of multiparametric 3.0 tesla magnetic resonance imaging in prostate cancer patients eligible for active surveillance. BJU Int 2013. [Epub ahead of print]. doi: 10.1111/bju.12423.